Current stock page

Stock Analysis

Absci Corporation (ABSI) Stock Analysis

Absci Corporation (ABSI) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

ABSI Stock Analysis Summary

Absci Corporation (ABSI) currently has an AIQ Score of 53/100, indicating a neutral setup. Momentum is the strongest factor at 85/100. Quality is the weakest current factor at 26/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data

ABSI at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$8.45
AIQ Score53/100
Overall ViewNeutral
Technical Analysis ConsensusSell
Market Cap$1.45B
P/E Ratio (TTM)-10.7
Forward P/E—
EPS (Q3 FY2026)-$0.19
Revenue (Q3 FY2026)$304K
Dividend Yield (TTM)0.00%
Beta3.28
Volume5.49M
52-week range$2.24-$12.54
RSI 1442.01
50-Day SMA$9.65
200-Day SMA$6.83
Analyst Price Target$14.50
Next Earnings—
As of Nov 13, 2026 · Market close

ABSIAbsci Corporation

Healthcare / Biotechnology

Relative Leader / Watch

Strong Relative Position

NeutralEdge 9/10
$8.45−$0.69 (−7.50%)

Latest quote

  • Momentum
    85
  • Value
    —
  • Quality
    26
  • Risk resilience
    30
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

ABSI Stock Analysis Summary

Absci Corporation (ABSI) currently has an AIQ Score of 53/100, indicating a neutral setup. Momentum is the strongest factor at 85/100. Quality is the weakest current factor at 26/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data
AIQ Composite Posture: Neutral

In a neutral regime, ABSI has AIQ Score of 53/100 with Momentum base of 85/100 and fading Quality at 26/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Momentum (85/100) leads while Quality (26/100) lags. This cross-factor spread creates entry timing uncertainty.

Healthcare · -7.50% stock move · ABSI classified in Biotechnology.

Current Evidence

NeutralABSI is in a neutral AIQ regime; Momentum is the strongest visible factor at 85/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is ABSI Bullish or Bearish Right Now?

ABSI currently has a neutral overall setup. Momentum is the strongest factor at 85/100, while Quality is weakest at 26/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.

Bull Case
  • - Momentum is constructive at 85/100.
  • - Analyst target implies +71.60% upside from the latest quote.
Bear Case
  • - Risk Resilience is weak at 30/100.
  • - Technical consensus has more sell votes than buy votes (31 vs 12).

Current Consensus

ABSI's Technical Analysis Consensus is currently Sell, with 12 buy, 3 neutral, and 31 sell votes. ABSI's 14-day RSI is 42.01, which places the stock in a weaker momentum range. ABSI's beta is 3.28, indicating greater market sensitivity than the broad market.

Signal Confidence
High agreement

What Changed in ABSI?

The largest recent change in ABSI is Momentum moving down by 4.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.

AIQ Score
-2.0
Momentum
-4.0
Quality
-2.0
Risk
+0.0

What Would Change the ABSI Outlook?

The current neutral outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

ABSI Decision Framework

Public evidence layers, setup checks, and risk context for Absci Corporation.

Absci Corporation (ABSI) Stock Analysis

Absci Corporation has an AIQ Score of 53/100 in a Neutral regime. Momentum is strongest at 85/100. Beta is 3.28, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextABSI is in a Neutral AIQ regime with score 53/100.
Signal ConflictThe primary conflict is that momentum leads at 85/100 while quality lags at 26/100.
Factor EvidenceMomentum 85/100 · Quality 26/100 · Risk 30/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthPass

Momentum is the strongest factor at 85/100.

TimingPass

Momentum is 85/100 and RSI (14) is 42.0.

Regime fitWait

ABSI is in a Neutral regime at 53/100.

Risk controlFail

Risk factor is 30/100 with beta 3.28 and annual volatility 104.15%.

ConflictWait

Current conflict: momentum leads at 85/100 while quality lags at 26/100.

AIQ Score
53/100
Price
$8.45
Beta
3.28
RSI (14)
42

ABSI Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

ABSI Fundamentals

ABSI valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$304K
Net income
-$33.3M
Free cash flow
-$29.48M
View full ABSI fundamental analysis

ABSI Technical Analysis

ABSI technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Sell
RSI 14
42.01
Price vs SMA-50
-12.47%
View full ABSI technical analysis

ABSI Stock Catalysts

Track ABSI earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
—
Analyst target
$14.50
News items
4
View ABSI earnings and stock catalysts

ABSI Dividend Analysis

ABSI dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
0.00%
Annual dividend
—
Payout ratio
—
View ABSI dividend history and analysis

ABSI Financial Data

ABSI revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$304K
EPS
-$0.19
Periods
8
View ABSI financials

ABSI Risk Analysis

ABSI volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
3.28
Risk score
30/100
1Y volatility
104.15%
View ABSI risk analysis

ABSI Stock News

ABSI stock news, market tone, recent headlines, and catalyst context.

News items
4
Updated
Nov 15, 2026
Sentiment
—
Read ABSI stock news

ABSI vs Biotechnology Peers

Current peer cohort: ABSI · ABUS · ABVX · ADMA · AGIO. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
ABSI
Current stock
53/100—85/10030/1001.58104.15%Current
ABUS
Arbutus Biopharma Corp
70/10092/10051/10062/100-0.0945.89%ABSI vs ABUS
ABVX
Abivax S.A.
35/100—34/10037/1000.2486.44%ABSI vs ABVX
ADMA
ADMA Biologics, Inc.
78/10080/10091/10056/100-0.0158.93%ABSI vs ADMA
AGIO
Agios Pharmaceuticals, Inc.
56/10052/10061/10047/1000.0779.96%ABSI vs AGIO
Pairwise Compare links: ABUS · ABVX · ADMA · AGIOABSI vs ABUSABSI vs ABVXABSI vs ADMAABSI vs AGIOCompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 13, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Nov 13, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a ABSI stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

Also for ABSI: historical return with reinvested dividends and stock average calculator for several buys.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Nov 16, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
-10.7
As of Nov 13, 2026
Revenue growth
-19.58%
Gross margin
-2647.41%
Current debt / equity
0.02
Latest quarterly evidence

Latest period Sep 30, 2026.

Review fundamentals
Quarter revenue
$304K
Quarter net income
-$33.3M
Quarter free cash flow
-$29.48M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Mixed
Momentum
Bearish
RSI 14
42.01
MACD
-0.06

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
30/100
Beta
3.28
Annual volatility
104.15%
Max drawdown
-42.79%

ABSI Stock FAQ

What is ABSI stock price today?

Absci Corporation's current stock price is $8.45. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is ABSI bullish or bearish right now?

ABSI's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is ABSI's market cap?

ABSI's market cap is $1.45B based on the latest completed market-close snapshot from Nov 13, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is ABSI's current P/E ratio?

ABSI's current P/E ratio is -10.7 based on the latest completed market-close snapshot from Nov 13, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is ABSI's RSI?

ABSI's 14-day RSI is 42.01 based on the latest completed market-close snapshot from Nov 13, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is ABSI above its 50-day and 200-day moving averages?

ABSI is -12.47% from its 50-day SMA and 23.70% from its 200-day SMA based on the latest completed market-close snapshot from Nov 13, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is ABSI's next earnings date?

ABSI's next earnings date is a key event to check before making a decision. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does ABSI pay a dividend?

ABSI's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 13, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.